| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,027 |
4,703 |
$199K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
952 |
889 |
$56K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
468 |
447 |
$28K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
516 |
494 |
$24K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
540 |
521 |
$23K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
722 |
681 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
209 |
207 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
355 |
175 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
42 |
41 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
224 |
220 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
26 |
$35.28 |